{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T11:14:31Z","timestamp":1788779671115,"version":"build-2803163510"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,14]]},"DOI":"10.7759\/cureus.84073","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:07:36Z","timestamp":1747206456000},"source":"Crossref","is-referenced-by-count":3,"title":["Diagnostic Value of Inflammatory Markers in Inflammatory Bowel Disease: Clinical and Endoscopic Correlations"],"prefix":"10.7759","author":[{"given":"Nazdar","family":"Omer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shereen","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali  A","family":"Ramadhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izz104","article-title":"The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation","volume":"26","author":"Park KT","year":"2020","unstructured":"Park KT, Ehrlich OG, Allen JI, et al.. The cost of inflammatory bowel disease: an initiative from the Crohn\u2019s & Colitis Foundation. Inflamm Bowel Dis. 2020, 26:1-10. 10.1093\/ibd\/izz104","journal-title":"Inflamm Bowel Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/7247238","article-title":"A comprehensive review and update on the pathogenesis of inflammatory bowel disease","volume":"2019","author":"Guan Q","year":"2019","unstructured":"Guan Q. A comprehensive review and update on the pathogenesis of inflammatory bowel disease. J Immunol Res. 2019, 2019:7247238. 10.1155\/2019\/7247238","journal-title":"J Immunol Res"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00942","article-title":"Interactions between intestinal microbiota and host immune response in inflammatory bowel disease","volume":"8","author":"Zhang M","year":"2017","unstructured":"Zhang M, Sun K, Wu Y, Yang Y, Tso P, Wu Z. Interactions between intestinal microbiota and host immune response in inflammatory bowel disease. Front Immunol. 2017, 8:942. 10.3389\/fimmu.2017.00942","journal-title":"Front Immunol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0233811","article-title":"Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: a prospective observational study","volume":"15","author":"Mavropoulou E","year":"2020","unstructured":"Mavropoulou E, Mechie NC, Knoop R, et al.. Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: a prospective observational study. PLoS One. 2020, 15:e0233811. 10.1371\/journal.pone.0233811","journal-title":"PLoS One"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2021.4940","article-title":"Interleukin\u20116 signalling as a valuable cornerstone for molecular medicine (review)","volume":"47","author":"Trovato M","year":"2021","unstructured":"Trovato M, Sciacchitano S, Facciol\u00e0 A, Valenti A, Visalli G, Di Pietro A. Interleukin\u20116 signalling as a valuable cornerstone for molecular medicine (review). Int J Mol Med. 2021, 47:107. 10.3892\/ijmm.2021.4940","journal-title":"Int J Mol Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01558","article-title":"Biology of interleukin-17 and its pathophysiological significance in sepsis","volume":"11","author":"Ge Y","year":"2020","unstructured":"Ge Y, Huang M, Yao YM. Biology of interleukin-17 and its pathophysiological significance in sepsis. Front Immunol. 2020, 11:1558. 10.3389\/fimmu.2020.01558","journal-title":"Front Immunol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.111427","article-title":"CXCL8 chemokine in ulcerative colitis","volume":"138","author":"Zhu Y","year":"2021","unstructured":"Zhu Y, Yang S, Zhao N, Liu C, Zhang F, Guo Y, Liu H. CXCL8 chemokine in ulcerative colitis. Biomed Pharmacother. 2021, 138:111427. 10.1016\/j.biopha.2021.111427","journal-title":"Biomed Pharmacother"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6517549","article-title":"Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease","volume":"2019","author":"Xu M","year":"2019","unstructured":"Xu M, Cen M, Chen X, Chen H, Liu X, Cao Q. Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease. Biomed Res Int. 2019, 2019:6517549. 10.1155\/2019\/6517549","journal-title":"Biomed Res Int"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1159\/000511641","article-title":"Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?","volume":"39","author":"Dragoni G","year":"2021","unstructured":"Dragoni G, Innocenti T, Galli A. Biomarkers of inflammation in inflammatory bowel disease: how long before abandoning single-marker approaches?. Dig Dis. 2021, 39:190-203. 10.1159\/000511641","journal-title":"Dig Dis"},{"key":"ref10","article-title":"Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study","volume":"70","author":"Best WR","year":"1976","unstructured":"Best WR, Becktel JM, Singleton JW, Kern F Jr. Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976, 70:439-44.","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjv210","article-title":"The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score","volume":"10","author":"Ikeya K","year":"2016","unstructured":"Ikeya K, Hanai H, Sugimoto K, et al.. The ulcerative colitis endoscopic index of severity more accurately reflects clinical outcomes and long-term prognosis than the Mayo endoscopic score. J Crohns Colitis. 2016, 10:286-95. 10.1093\/ecco-jcc\/jjv210","journal-title":"J Crohns Colitis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10071492","article-title":"The current status of molecular biomarkers for inflammatory bowel disease","volume":"10","author":"Alghoul Z","year":"2022","unstructured":"Alghoul Z, Yang C, Merlin D. The current status of molecular biomarkers for inflammatory bowel disease. Biomedicines. 2022, 10:1492. 10.3390\/biomedicines10071492","journal-title":"Biomedicines"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s43162-022-00115-x","article-title":"A decade of inflammatory bowel disease: a single center experience in Egypt","volume":"34","author":"Shamkh MAA","year":"2022","unstructured":"Shamkh MAA, Sakr MA, Alaty WH, et al.. A decade of inflammatory bowel disease: a single center experience in Egypt. Egypt J Intern Med. 2022, 34:10.1186\/s43162-022-00115-x","journal-title":"Egypt J Intern Med"},{"key":"ref14","article-title":"The subpopulations of circulating white blood cells in inflammatory bowel disease","volume":"71","author":"Thayer WR Jr","year":"1976","unstructured":"Thayer WR Jr, Charland C, Field CE. The subpopulations of circulating white blood cells in inflammatory bowel disease. Gastroenterology. 1976, 71:379-84.","journal-title":"Gastroenterology"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s12876-024-03305-9","article-title":"Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis","volume":"24","author":"Xu C","year":"2024","unstructured":"Xu C, Song Z, Hu LT, Tong YH, Hu JY, Shen H. Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis. BMC Gastroenterol. 2024, 24:214. 10.1186\/s12876-024-03305-9","journal-title":"BMC Gastroenterol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.880553","article-title":"Trends in worldwide research in inflammatory bowel disease over the period 2012-2021: a bibliometric study","volume":"9","author":"Li K","year":"2022","unstructured":"Li K, Feng C, Chen H, Feng Y, Li J. Trends in worldwide research in inflammatory bowel disease over the period 2012-2021: a bibliometric study. Front Med (Lausanne). 2022, 9:880553. 10.3389\/fmed.2022.880553","journal-title":"Front Med (Lausanne)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/gastroent15020034","article-title":"Cytokine signatures in inflamed mucosa of IBD patients: state-of-the-art","volume":"15","author":"Peruhova M","year":"2024","unstructured":"Peruhova M, Miteva D, Kokudeva M, Banova S, Velikova T. Cytokine signatures in inflamed mucosa of IBD patients: state-of-the-art. Gastroenterol Insights. 2024, 15:471-85. 10.3390\/gastroent15020034","journal-title":"Gastroenterol Insights"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-217927","article-title":"Paradoxical gastrointestinal effects of interleukin-17 blockers","volume":"79","author":"Fauny M","year":"2020","unstructured":"Fauny M, Moulin D, D'Amico F, et al.. Paradoxical gastrointestinal effects of interleukin-17 blockers. Ann Rheum Dis. 2020, 79:1132-8. 10.1136\/annrheumdis-2020-217927","journal-title":"Ann Rheum Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231810281","article-title":"Elevated IL-6 and IL-22 in early pregnancy are associated with worse disease course in women with inflammatory bowel disease","volume":"23","author":"Wu RY","year":"2022","unstructured":"Wu RY, Xiao K, Hotte N, et al.. Elevated IL-6 and IL-22 in early pregnancy are associated with worse disease course in women with inflammatory bowel disease. Int J Mol Sci. 2022, 23:10281. 10.3390\/ijms231810281","journal-title":"Int J Mol Sci"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3390\/medicina56080382","article-title":"Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases","volume":"56","author":"Viscido A","year":"2020","unstructured":"Viscido A, Capannolo A, Petroni R, et al.. Association between corrected QT interval and C-reactive protein in patients with inflammatory bowel diseases. Medicina (Kaunas). 2020, 56:382. 10.3390\/medicina56080382","journal-title":"Medicina (Kaunas)"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.24996\/ijs.2021.62.8.5","article-title":"Roles of IL-17A and IL-23 in the pathogenesis of ulcerative colitis and Crohn\u2019s disease","volume":"8","author":"Abdul-Hussein SS","year":"2021","unstructured":"Abdul-Hussein SS, Ali EN, Alkhalidi NMF, Zaki NH, Ad'hiah AH. Roles of IL-17A and IL-23 in the pathogenesis of ulcerative colitis and Crohn\u2019s disease. Iraq J Sci. 2021, 8:2526-35. 10.24996\/ijs.2021.62.8.5","journal-title":"Iraq J Sci"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.21608\/eajbsc.2022.221330","article-title":"Pentraxin-3: a novel specific biomarker for inflammatory bowel disease diagnosis","volume":"1","author":"Ibrahim IO","year":"2022","unstructured":"Ibrahim IO, Massoud IM, El-Hadidy WF. Pentraxin-3: a novel specific biomarker for inflammatory bowel disease diagnosis. Egypt Acad J Biol Sci. 2022, 1:153-63. 10.21608\/eajbsc.2022.221330","journal-title":"Egypt Acad J Biol Sci"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.4414\/smw.2012.13557","article-title":"Faecal calprotectin-a useful tool in the management of inflammatory bowel disease","volume":"142","author":"Burri E","year":"2012","unstructured":"Burri E, Beglinger C. Faecal calprotectin-a useful tool in the management of inflammatory bowel disease. Swiss Med Wkly. 2012, 142:w13557. 10.4414\/smw.2012.13557","journal-title":"Swiss Med Wkly"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2013-100420","article-title":"Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?","volume":"6","author":"Dhaliwal A","year":"2015","unstructured":"Dhaliwal A, Zeino Z, Tomkins C, et al.. Utility of faecal calprotectin in inflammatory bowel disease (IBD): what cut-offs should we apply?. Frontline Gastroenterol. 2015, 6:14-9. 10.1136\/flgastro-2013-100420","journal-title":"Frontline Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2022.01.024","article-title":"Disease monitoring in inflammatory bowel disease: evolving principles and possibilities","volume":"162","author":"Plevris N","year":"2022","unstructured":"Plevris N, Lees CW. Disease monitoring in inflammatory bowel disease: evolving principles and possibilities. Gastroenterology. 2022, 162:1456-1475.e1. 10.1053\/j.gastro.2022.01.024","journal-title":"Gastroenterology"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2014.2180","article-title":"Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome","volume":"10","author":"Chang MH","year":"2014","unstructured":"Chang MH, Chou JW, Chen SM, Tsai MC, Sun YS, Lin CC, Lin CP. Faecal calprotectin as a novel biomarker for differentiating between inflammatory bowel disease and irritable bowel syndrome. Mol Med Rep. 2014, 10:522-6. 10.3892\/mmr.2014.2180","journal-title":"Mol Med Rep"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1186\/s13317-019-0114-8","article-title":"Neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity","volume":"10","author":"Okba AM","year":"2019","unstructured":"Okba AM, Amin MM, Abdelmoaty AS, Ebada HE, Kamel AH, Allam AS, Sobhy OM. Neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity. Auto Immun Highlights. 2019, 10:4. 10.1186\/s13317-019-0114-8","journal-title":"Auto Immun Highlights"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/367670-diagnostic-value-of-inflammatory-markers-in-inflammatory-bowel-disease-clinical-and-endoscopic-correlations","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T07:07:37Z","timestamp":1747206457000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/367670-diagnostic-value-of-inflammatory-markers-in-inflammatory-bowel-disease-clinical-and-endoscopic-correlations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.84073","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5,14]]}}}